Pediatric/adolescent and young adult patient, donor, and allograft characteristics (n = 29)
| Characteristic . | Value . |
|---|---|
| Age at BMT, median (range), y | 14 (0-24) |
| Patient sex, male, n (%) | 16 (55) |
| Disease, n (%) | |
| AML | 6 (21) |
| CR1 | |
| MRDneg | 2 |
| MRDpos | 1 |
| CR ≥2 | |
| MRDneg | 3 |
| MRDpos | 0 |
| ALL | 10 (35) |
| CR1 | |
| MRDneg | 3 |
| MRDpos | 1 |
| CR ≥2 | |
| MRDneg | 3 |
| MRDpos | 3 |
| Mixed lineage leukemia | 2 (7) |
| MDS | 3 (10) |
| Active | 3 |
| Lymphoma | 7 (24) |
| CR | 4 |
| Partial remission | 3 |
| Other | 1 (3) |
| DRI, n (%) | |
| Low | 1 (4) |
| Intermediate | 16 (55) |
| High | 12 (41) |
| Conditioning, n (%) | |
| Bu/Cy | 16 (55) |
| Cy/TBI | 13 (45) |
| Donor age, median (range), y | 33 (11-58) |
| Donor sex, male, n (%) | 9 (31) |
| Sex mismatch, n (%) | |
| Female donor to male recipient | 12 (41) |
| Male donor to female recipient | 5 (18) |
| None | 12 (41) |
| Graft cell counts | |
| Nucleated cells/kg infused × 108 | 5.5 (3-12) |
| CD34+/kg infused × 106 | 5.4 (2.5-12.4) |
| CD3+/kg infused × 107 | 5.4 (2.3-11.67) |
| CMV at risk, n (%) | 18 (62) |
| Median no. of HLA allele mismatches | 4/10 |
| ABO incompatibility, n (%) | |
| Major | 3 (10) |
| Minor | 1 (3) |
| None | 25 (86) |
| Characteristic . | Value . |
|---|---|
| Age at BMT, median (range), y | 14 (0-24) |
| Patient sex, male, n (%) | 16 (55) |
| Disease, n (%) | |
| AML | 6 (21) |
| CR1 | |
| MRDneg | 2 |
| MRDpos | 1 |
| CR ≥2 | |
| MRDneg | 3 |
| MRDpos | 0 |
| ALL | 10 (35) |
| CR1 | |
| MRDneg | 3 |
| MRDpos | 1 |
| CR ≥2 | |
| MRDneg | 3 |
| MRDpos | 3 |
| Mixed lineage leukemia | 2 (7) |
| MDS | 3 (10) |
| Active | 3 |
| Lymphoma | 7 (24) |
| CR | 4 |
| Partial remission | 3 |
| Other | 1 (3) |
| DRI, n (%) | |
| Low | 1 (4) |
| Intermediate | 16 (55) |
| High | 12 (41) |
| Conditioning, n (%) | |
| Bu/Cy | 16 (55) |
| Cy/TBI | 13 (45) |
| Donor age, median (range), y | 33 (11-58) |
| Donor sex, male, n (%) | 9 (31) |
| Sex mismatch, n (%) | |
| Female donor to male recipient | 12 (41) |
| Male donor to female recipient | 5 (18) |
| None | 12 (41) |
| Graft cell counts | |
| Nucleated cells/kg infused × 108 | 5.5 (3-12) |
| CD34+/kg infused × 106 | 5.4 (2.5-12.4) |
| CD3+/kg infused × 107 | 5.4 (2.3-11.67) |
| CMV at risk, n (%) | 18 (62) |
| Median no. of HLA allele mismatches | 4/10 |
| ABO incompatibility, n (%) | |
| Major | 3 (10) |
| Minor | 1 (3) |
| None | 25 (86) |